Hellgren et al v. Pfizer, Inc et al

Filing 12

ORDER GRANTING 7 STIPULATION. Signed by Judge JEFFREY S. WHITE on 3/1/12. (jjoS, COURT STAFF) (Filed on 3/1/2012)

Download PDF
Case3:12-cv-00735-JSW Document7 Filed02/24/12 Page1 of 4 1 2 3 4 5 6 7 8 WHITE & CASE LLP BIJAL V. VAKIL (SBN 192878) bvakil@whitecase.com 5 Palo Alto Square, 9th Floor 3000 El Camino Real Palo Alto, CA 94306 Telephone: (650) 213-0300 Facsimile: (650) 213-8158 Counsel for Defendants PFIZER INC., PFIZER IRELAND PHARMACEUTICALS, and WARNER-LAMBERT COMPANY LLC 9 UNITED STATES DISTRICT COURT 10 NORTHERN DISTRICT OF CALIFORNIA SAN FRANCISCO DIVISION 12 SILICON VALLEY ATTORNEYS AT LAW W HITE & C ASE LLP 11 13 SANDRA HELLGREN, an individual, and BERNARD A. ORSI, an individual, 14 15 16 17 18 19 20 Civil Action No.: 3:12-cv-0735 (NC) (JSW) Plaintiffs, STIPULATION AND [PROPOSED] ORDER v. PFIZER, INC., a Delaware Corporation, PFIZER IRELAND PHARMACEUTICALS, an Irish partnership, WARNER-LAMBERT COMPANY, formerly a Delaware Corporation, WARNERLAMBERT COMPANY LLC, a Delaware limited liability company, RANBAXY, INC., a Delaware Corporation, and DOES 1-10, Defendants. 21 22 23 24 25 26 27 28 1 Magistrate Judge Nathanael M. Cousins Case3:12-cv-00735-JSW Document7 Filed02/24/12 Page2 of 4 1 2 WHEREAS the Notice of Removal of Action from State Court in the above-captioned action was filed on February 15, 2012; and 3 WHEREAS Plaintiffs Sandra Hellgren and Bernard A. Orsi (collectively, “Plaintiffs”) 4 served Defendants Pfizer Inc., Pfizer Ireland Pharmaceuticals, and Warner-Lambert Company 5 LLC (collectively, “Pfizer”) with a copy of the First Amended Complaint on January 17, 2012; 6 and 7 WHEREAS at least nine other actions have been filed in federal and state courts to date (“JPML”) to transfer and coordinate these related federal actions, including the above-captioned 11 action, pursuant to 28 U.S.C. § 1407. In re: Lipitor Antitrust Litigation, MDL No. 2332. A 12 SILICON VALLEY competitors. A petition is currently pending before the Judicial Panel on Multidistrict Litigation 10 ATTORNEYS AT LAW challenging Pfizer’s allegedly anticompetitive conduct with regard to Lipitor and its generic 9 W HITE & C ASE LLP 8 hearing to consider the transfer and coordination of the actions in MDL No. 2332 is set for March 13 29, 2012; and 14 WHEREAS Plaintiffs and Pfizer have met and conferred on this issue in good faith; 15 IT IS HEREBY STIPULATED AND AGREED, by Plaintiffs and Pfizer, through their 16 respective counsel, that the deadline for Pfizer to answer or otherwise respond to Plaintiffs’ First 17 Amended Complaint shall be extended to fourteen (14) days after the date the JPML issues a 18 ruling or decision regarding transfer and consolidation of actions in MDL No. 2332. The parties 19 reserve their right to discovery in accordance with the Federal Rules of Civil Procedure and/or 20 Civil Local Rules. 21 Respectfully submitted, 22 23 Dated: February 24, 2012 24 25 26 27 /s/ Bijal V. Vakil Bijal V. Vakil, Esq. WHITE & CASE LLP 5 Palo Alto Square, 9th Floor 3000 El Camino Real Palo Alto, California 94306 Tel. 650 213 0300 Fax. 650 213 8158 Counsel for Defendants -2- 28 PALOALTO 110068 STIPULATION AND PROPOSED ORDER CASE NO. 3:12-CV-0735 (NC) Case3:12-cv-00735-JSW Document7 Filed02/24/12 Page3 of 4 PFIZER INC., PFIZER IRELAND PHARMACEUTICALS, and WARNER-LAMBERT COMPANY LLC 1 2 3 Dated: February 24, 2012 4 5 6 7 /s/ Lawrence G. Papale Lawrence G. Papale, Esq. LAW OFFICE OF LAWRENCE G. PAPALE 1308 Main Street, Suite 117 St. Helena, CA 94574 Tel. (707) 963-1704 Fax. (707) 963-0706 Counsel for Plaintiffs SANDRA HELLGREN and BERNARD A. ORSI 8 9 10 11 SILICON VALLEY ATTORNEYS AT LAW W HITE & C ASE LLP 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 -3PALOALTO 110068 STIPULATION AND PROPOSED ORDER CASE NO. 3:12-CV-0735 (NC) Case3:12-cv-00735-JSW Document7 Filed02/24/12 Page4 of 4 1 2 ATTESTATION CLAUSE I, Bijal V. Vakil, hereby attest in accordance with General Order No. 45.X that Lawrence 3 G. Papale, Counsel for Plaintiffs has provided his concurrence with the electronic filing of the 4 foregoing document entitled STIPULATION AND [PROPOSED] ORDER. 5 Dated: February 24, 2012 WHITE & CASE LLP 6 7 By: 8 /s/ Bijal V. Vakil Bijal V. Vakil Counsel for Defendants PFIZER INC., PFIZER IRELAND PHARMACEUTICALS, and WARNER-LAMBERT COMPANY LLC 9 10 11 SILICON VALLEY ATTORNEYS AT LAW W HITE & C ASE LLP 12 13 14 15 16 17 18 ORDER Pursuant to the above Stipulation filed in this action, it is hereby ORDERED that the time within which Defendants Pfizer Inc., Pfizer Ireland Pharmaceuticals, and WarnerLambert Company LLC may answer or otherwise respond to Plaintiffs’ First Amended 19 Complaint is hereby extended to fourteen (14) days after the date the Judicial Panel on 20 Multidistrict Litigation (“JPML”) issues a ruling or decision regarding the transfer and 21 coordination of actions in In re: Lipitor Antitrust Litigation, MDL No. 2332. 22 23 March 1, 2012 Dated: _____________________ 24 __ NATHANAEL M. COUSINS MAGISTRATE JUDGE JEFFREY S. WHITE DISTRICT COURT JUDGE 25 26 27 28 -4PALOALTO 110068 STIPULATION AND PROPOSED ORDER CASE NO. 3:12-CV-0735 (NC)

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?